First Manhattan Co. LLC Reports New 9.6% Stake in PAVmed Inc. (PAVM)

On May 14, 2026, First Manhattan Co. LLC, alongside FMC Group Holdings LP and First Manhattan Management LLC, filed a Schedule 13G with the SEC disclosing a new 9.6% ownership stake in PAVmed Inc. (PAVM). The reporting persons collectively hold 639,191 shares of common stock as of the event date on March 31, 2026. This represents a significant increase from a previous 0.0% position, establishing the group as a major institutional shareholder. The filing indicates that First Manhattan Co. LLC holds sole voting and dispositive power over 638,720 shares, with shared power over the remaining 471 shares. The acquisition was made in the ordinary course of business, and the filers certified that the shares were not acquired with the intent to change or influence the control of the issuer. PAVmed Inc., a medical technology company, is headquartered in New York, and the investment reflects a substantial new commitment by the New York-based investment advisor.